In this context, ACBD3 has minimal or moderate impact on cell proliferation but acts as a negative regulator of NOTCH signaling, resulting in reduced SNAI1 expression and impaired cell motility in mesenchymal lung cancer cells. This evidence concerns the gene ACBD3 and lung carcinoma.